Wockhardt Ltd is a pharmaceutical company based in India, specializing in drug manufacturing and biotechnology products. With a Risk Rating Score of 41.3, the company is considered to be at severe risk. Wockhardt conducts research in pharmaceuticals and biotechnology, in addition to running Super Specialty Hospitals. While it generates most of its revenue in Europe, Wockhardt also operates in the USA, Japan, Russia, and other parts of the world. Prioritizing ESG standards, Wockhardt is committed to environmental sustainability and strong governance practices.